Melatonin: possible implications for the postoperative and critically ill patient.

Area of Science:

• Endocrinology
• Sleep Medicine
• Critical Care Medicine

Background:

• Melatonin, a hormone regulating sleep-wake cycles and circadian rhythms, is being investigated for its potential benefits in postoperative and critically ill patients.
• Its antioxidant properties may help mitigate issues like ischemia-reperfusion injury, multi-organ failure, and sepsis, which are common in these patient populations.

Purpose of the Study:

• To explore the potential roles of melatonin in managing sleep disorders, circadian rhythm disturbances, and oxidative stress in surgical and critically ill patients.
• To review the current evidence regarding melatonin's efficacy in preventing or treating postoperative delirium and improving sleep in the critically ill.

Main Methods:

• Literature review and synthesis of existing research on melatonin's physiological roles and clinical applications.
• Exploration of melatonin's interaction with surgical/critical illness stressors, focusing on circadian rhythms, sleep, delirium, and antioxidant activity.

Main Results:

• While melatonin's antioxidant and circadian-regulating functions are recognized, current evidence is insufficient to support its routine use for preventing postoperative delirium.
• Disrupted melatonin secretion is linked to sleep disorders in critically ill patients, but data supporting routine melatonin supplementation is scarce.

Conclusions:

• Exogenous melatonin therapy shows potential but requires more robust clinical evidence before routine adoption in postoperative and critically ill patients.
• Further research is necessary to confirm the therapeutic benefits of melatonin for specific conditions like delirium and sleep disturbances in these vulnerable patient groups.